NeuroDerm

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NeuroDerm and buy or sell other stocks, ETFs, and their options commission-free!

About NDRM

NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. 

CEO
Kengo Isshiki
CEOKengo Isshiki
Employees
Employees
Headquarters
Rehovot, HaMerkaz
HeadquartersRehovot, HaMerkaz
Founded
2003
Founded2003
Employees
Employees

NDRM Key Statistics

Market cap
1.02B
Market cap1.02B
Price-Earnings ratio
-19.62
Price-Earnings ratio-19.62
Dividend yield
Dividend yield
Average volume
214.09K
Average volume214.09K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$38.95
52 Week high$38.95
52 Week low
$15.20
52 Week low$15.20

Stock Snapshot

The current NeuroDerm(NDRM) stock price is $38.85, with a market capitalization of 1.02B. The stock trades at a price-to-earnings (P/E) ratio of -19.62.

On 2026-04-14, NeuroDerm(NDRM) stock opened at —, reached a high of —, and a low of —.

NeuroDerm(NDRM) shares are trading with a volume of 0, against a daily average of 214.09K.

During the past year, NeuroDerm(NDRM) stock moved between $15.20 at its lowest and $38.95 at its peak.

During the past year, NeuroDerm(NDRM) stock moved between $15.20 at its lowest and $38.95 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.